[Hematologic Malignancies/Pediatric Malignancies. Roles of Drugs Approved as New Agents and as Additional Indications for Relapse or Refractory Hematologic Malignancies]. [electronic resource]
- Gan to kagaku ryoho. Cancer & chemotherapy May 2016
- 528-9 p. digital
Publication Type: Introductory Journal Article
0385-0684
Antineoplastic Agents--therapeutic use Child Drug Approval Hematologic Neoplasms--drug therapy Humans Recurrence